LAVA Therapeutics N.V. (NASDAQ: LVTX) Stock Information | RedChip

LAVA Therapeutics N.V. (NASDAQ: LVTX) Listen to this Section


$1.79
-0.0300 ( -1.65% ) 64.6K

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

Market Data


Open


$1.79

Previous close


$1.82

Volume


64.6K

Market cap


$47.06M

Day range


$1.78 - $1.88

52 week range


$1.13 - $6.47

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 1 Jun 20, 2024
6-k Quarterly Reports 30 Jun 06, 2024
6-k Quarterly Reports 4 May 21, 2024
6-k Quarterly Reports 2 Mar 21, 2024
20-f Annual reports 116 Mar 20, 2024
6-k Quarterly Reports 4 Nov 16, 2023
6-k Quarterly Reports 4 Aug 22, 2023
6-k Quarterly Reports 45 Aug 15, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.